Maite Gorostegui: Our paper about Management of High-Risk Neuroblastoma in the Era of Anti-GD2 Immunotherapy

Francisco J. Esteva: 5 common myths or misconceptions about cancer immunotherapy

Pashtoon Kasi: Why would neoadjuvant immunotherapy work better

NCI Center for Cancer Research – Sandra Wolin, Steven Rosenberg, Giorgio Trinchieri from NCI CCR were elected into National Academy of Sciences

Ramy Sedhom: In lockstep with the ASCO Presidential Theme – Palliative Care is on the stage as a plenary at this year’s Annual Meeting

It’s the one-two punch cancer treatment that ‘floats like a butterfly, and STINGs like a bee’! – WEHI (Walter and Eliza Hall Institute of Medical Research)

Harriet Kluger has accepted accepted candidacy for At-Large Director in Society for Immunotherapy of Cancer (SITC) – Yale Cancer Center

Martin Stumpe: Predicting MSI in prostate cancer from hematoxylin and eosin stained biopsy

Pashtoon Kasi: Time to revise assessment methods to reflect the pattern

Nicola Ferrari: Principles and therapeutic applications of adaptive immunity